Manufacturer of Controlled Substances; Notice of Registration; Cayman Chemical Company

Federal Register, Volume 77 Issue 123 (Tuesday, June 26, 2012)

Federal Register Volume 77, Number 123 (Tuesday, June 26, 2012)

Notices

Pages 38085-38086

From the Federal Register Online via the Government Printing Office www.gpo.gov

FR Doc No: 2012-15607

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Registration; Cayman Chemical Company

By Notice dated March 8, 2012, and published in the Federal Register on March 20, 2012, 77 FR 16263, Cayman Chemical Company, 1180 East Ellsworth Road, Ann Arbor, Michigan 48108, made application to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances:

------------------------------------------------------------------------

Drug Schedule

------------------------------------------------------------------------

4-Methyl-N-methylcathinone (1248).......... I

Gamma Hydroxybutyric Acid (2010)........... I

Mescaline (7381)........................... I

N-Benzylpiperazine (7493).................. I

3,4-Methylenedioxyprovalerone (7535)....... I

3,4-Methylenedioxy-N-methylcathinone (7540) I

------------------------------------------------------------------------

The company plans to manufacture the above listed controlled substances to supply these materials to the research and forensics community for drug testing and analysis.

Page 38086

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cayman Chemical Company to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Cayman Chemical Company to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history.

Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR Sec. 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

Dated: June 18, 2012.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

FR Doc. 2012-15607 Filed 6-25-12; 8:45 am

BILLING CODE 4410-09-P

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT